Meaningful Use Assessment

Meaningful Use Assessments can help companies develop a roadmap with clear steps.  The HITECH Act provides incentives for Medicare and Medicaid providers to achieve Meaningful Use of Electronic Medical Records.  The Meaningful Use Assessment may include these phases and components:

  • Meaningful Use Project Governance
  • Meaningful Use rapid assessment of the current organization and requirements
  • Meaningful Use Business Case and Return on Investment (ROI)
  • Meaningful Use Executive and Stakeholder Awareness training
  • Meaningful Use Business road map development for Stage 1 and Stage 2 to clearly define opportunities and priorities
  • Meaningful Use Stage 3 – understanding patient engagement
  • Meaningful Use specialty medicine / specialty practice approaches for Radiology, Oncology, Cardiology, Orthopedics and other practice areas.
  • Meaningful Use quality measure benefits awareness training
  • Meaningful Use Interoperability Assessment based on HHS ONC standards
  • Meaningful Use in-depth Training
  • Meaningful Use High-level review and skills inventory
  • Meaningful Use In-Depth Assessment and ICD-10 Gap Analysis
  • Implementation Planning & Design
  • Electronic Medical Record vendor selection, vendor assessment, and contract reviews
  • Clinical Documentation Improvement with Electronic Medical Records
  • Synergies with ICD-10
  • Data migration planning
  • Vendor requirements for Ambulatory, or Inpatient per section 170.302
  • Security and privacy assessment per section 170.302
  • Implementation
  • Selection of a vendor that has been certified by an Authorized Testing and Certification Body (ATCB)
  • Vendor Readiness Assessments
  • Business Test Plan Review

MU impacts these organizations:

  • Hospitals (including Inpatient and Acute Care, Community Access Hospitals, Academic Medical Centers & Federally Qualified Rural Health Centers)
  • Clinics (both stand alone and those affiliated with hospitals)
  • Physicians (private Physician practices, IPAs and other groups including specialty practices in Oncology, Gastroenterology, Nephrology, Obstetrics and Gynecology, Primary Care/Family Physicians.
  • Self-insured employers considering the benefits of Accountable Care Organizations
  • Patients
  • Vendors of Electronic Medical Records or Electronic Health Records Systems, Computerized Physician Order Entry (CPOE) and other modules
  • Service Providers who deliver information to the health care services industry, especially if information contains Personal Health Information (PHI)
  • Health plans that are interested in reducing costs of acquiring medical records for utilization and case management without using faxes and paper.
  • Regulatory Agencies

If you are preparing a Request for Proposal or are interested in our detail Meaningful Use Assessment Methodology, our nationally recognized experts and consulting team can help.

Related Posts

Michael F. Arrigo

Michael Arrigo, an expert witness, and healthcare executive, brings four decades of experience in the software, financial services, and healthcare industries. In 2000, Mr. Arrigo founded No World Borders, a healthcare data, regulations, and economics firm with clients in the pharmaceutical, medical device, hospital, surgical center, physician group, diagnostic imaging, genetic testing, health I.T., and health insurance markets. His expertise spans the federal health programs Medicare and Medicaid and private insurance. He advises Medicare Advantage Organizations that provide health insurance under Part C of the Medicare Act. Mr. Arrigo serves as an expert witness regarding medical coding and billing, fraud damages, and electronic health record software for the U.S. Department of Justice. He has valued well over $1 billion in medical billings in personal injury liens, malpractice, and insurance fraud cases. The U.S. Court of Appeals considered Mr. Arrigo's opinion regarding loss amounts, vacating, and remanding sentencing in a fraud case. Mr. Arrigo provides expertise in the Medicare Secondary Payer Act, Medicare LCDs, anti-trust litigation, medical intellectual property and trade secrets, HIPAA privacy, health care electronic claim data Standards, physician compensation, Anti-Kickback Statute, Stark law, the Affordable Care Act, False Claims Act, and the ARRA HITECH Act. Arrigo advises investors on merger and acquisition (M&A) diligence in the healthcare industry on transactions cumulatively valued at over $1 billion. Mr. Arrigo spent over ten years in Silicon Valley software firms in roles from Product Manager to CEO. He was product manager for a leading-edge database technology joint venture that became commercialized as Microsoft SQL Server, Vice President of Marketing for a software company when it grew from under $2 million in revenue to a $50 million acquisition by a company now merged into Cincom Systems, hired by private equity investors to serve as Vice President of Marketing for a secure email software company until its acquisition and multi $million investor exit by a company now merged into Axway Software S.A. (Euronext: AXW.PA), and CEO of one of the first cloud-based billing software companies, licensing its technology to Citrix Systems (NASDAQ: CTXS). Later, before entering the healthcare industry, he joined Fortune 500 company Fidelity National Financial (NYSE: FNF) as a Vice President, overseeing eCommerce solutions for the mortgage banking industry. While serving as a Vice President at Fortune 500 company First American Financial (NYSE: FAF), he oversaw eCommerce and regulatory compliance technology initiatives for the top ten mortgage banks and led the Sarbanes Oxley Act Section 302 internal controls I.T. audit for the company, supporting Section 404 of the Sarbanes Oxley Act. Mr. Arrigo earned his Bachelor of Science in Business Administration from the University of Southern California. Before that, he studied computer science, statistics, and economics at the University of California, Irvine. His post-graduate studies include biomedical ethics at Harvard Medical School, biomedical informatics at Stanford Medical School, blockchain and crypto-economics at the Massachusetts Institute of Technology, and training as a Certified Professional Medical Auditor (CPMA). Mr. Arrigo is qualified to serve as a director due to his experience in healthcare data, regulations, and economics, his leadership roles in software and financial services public companies, and his healthcare M&A diligence and public company regulatory experience. Mr. Arrigo is quoted in The Wall Street Journal, Fortune Magazine, Kaiser Health News, Consumer Affairs, National Public Radio (NPR), NBC News Houston, USA Today / Milwaukee Journal Sentinel, Medical Economics, Capitol ForumThe Daily Beast, the Lund Report, Inside Higher Ed, New England Psychologist, and other press and media outlets. He authored a peer-reviewed article regarding clinical documentation quality to support accurate medical coding, billing, and good patient care, published by Healthcare Financial Management Association (HFMA) and published in Healthcare I.T. News. Mr. Arrigo serves as a member of the board of directors of a publicly traded company in the healthcare and data analytics industry, where his duties include: member, audit committee; chair, compensation committee; member, special committee.

Leave a Reply